Jeffrey J Sands

US Patent:

8632485, Jan 21, 2014

Filed:

Nov 5, 2009

Appl. No.:

12/613394

Inventors:

Christian Schlaeper - Concord CA, US
Martin Crnkovich - Walnut Creek CA, US
Jeffrey J. Sands - Celebration FL, US

Assignee:

Fresenius Medical Care Holdings, Inc. - Waltham MA

International Classification:

A61M 37/00
C02F 1/44
G06Q 50/00

US Classification:

604 401, 604 501, 604 609, 210645, 210739, 705 3

Abstract:

The invention provides apparatus and methods for home or other remote delivery of health care that gather subjective and objective measures of patient health and treatment, analyzing them (e. g. , correlating them with one another and/or with norms) and reporting them to aid in on-going patient diagnosis and treatment (both on acute and chronic bases), as well as to aid physicians, nurses and other caregivers in decision support, monitoring treatment compliance, facilitating regulatory compliance, billing, and so forth. Thus, for example, in some aspects a health care delivery device comprising a medical treatment apparatus, such as a home hemodialysis or home peritoneal dialysis unit, that is coupled to a processor. The processor generates patient queries in connection with treatments rendered by the dialysis equipment (or other treatment apparatus). The queries are directed, at least in part, to subjective topics, such as the state of the patient's mental health and well being, quality of life, degrees of pain, views on success of therapy, and so forth.

US Patent:

20130211206, Aug 15, 2013

Filed:

Feb 15, 2012

Appl. No.:

13/397265

Inventors:

Jeffrey J. Sands - Celebration FL, US
Christian Schlaeper - Concord CA, US
Martin Crnkovich - Walnut Creek CA, US

International Classification:

A61B 5/00

US Classification:

600301

Abstract:

The invention provides a health care delivery system comprising a plurality of health care delivery devices (e.g., via the Internet, etc.), which can disposed in treatment centers ranging from patient homes to commercial health care facilities such as hospitals, dialysis centers and so forth. Reporting functionality can, instead of or in addition to identifying (and reporting on) discrepancies in the raw and/or analyzed data from the delivery devices, infer (and report) on possible causes of those discrepancies and, in some aspects of the invention, remedy those causes, thereby, providing automated operations support for the treatment centers.

US Patent:

20210257102, Aug 19, 2021

Filed:

Jan 6, 2021

Appl. No.:

17/142496

Inventors:

- Detroit MI, US
Brad ASTOR - Madison WI, US
Jeffrey J. SANDS - Orlando FL, US
Helen Kimball HIRSCHMAN - Evanston IL, US
Douglas CURRY - West Lafayette IN, US
Stanley FRINAK - Farmington Hills MI, US
Gerard ZASUWA - West Bloomfield MI, US
Jerry YEE - Beverly Hills MI, US
Anatole BESARAB - Bloomfield Hills MI, US
Lalathaksha KUMBAR - Troy MI, US

International Classification:

G16H 50/30
G16H 50/70
G16H 10/60

Abstract:

A method for determining risk of an adverse event, such as thrombosis or a required intervention, associated with a vascular access includes receiving hemodialysis treatment data associated with the vascular access, deriving a plurality of selected risk factors from the hemodialysis treatment data, evaluating the plurality of selected risk factors over a time period, assigning raw scores to each selected risk factor based on its values over the time period, summing the raw scores for the plurality of selected risk factors to determine a cumulative raw score, and correlating the cumulative raw score with a level of risk of an adverse event associated with the vascular access.

US Patent:

20200098479, Mar 26, 2020

Filed:

Sep 20, 2019

Appl. No.:

16/577574

Inventors:

- Detroit MI, US
Brad ASTOR - Madison WI, US
Jeffrey J. SANDS - Orlando FL, US
Helen Kimball HIRSCHMAN - Evanston IL, US
Douglas CURRY - West Lafayette IN, US
Stanley FRINAK - Farmington Hills MI, US
Gerard ZASUWA - West Bloomfield MI, US
Jerry YEE - Beverly Hills MI, US
Anatole BESARAB - Bloomfield Hills MI, US
Lalathaksha KUMBAR - Troy MI, US

International Classification:

G16H 50/30
G16H 10/60
G16H 50/70

Abstract:

A method for determining risk of an adverse event, such as thrombosis or a required intervention, associated with a vascular access includes receiving hemodialysis treatment data associated with the vascular access, deriving a plurality of selected risk factors from the hemodialysis treatment data, evaluating the plurality of selected risk factors over a time period, assigning raw scores to each selected risk factor based on its values over the time period, summing the raw scores for the plurality of selected risk factors to determine a cumulative raw score, and correlating the cumulative raw score with a level of risk of an adverse event associated with the vascular access.

US Patent:

20190314566, Oct 17, 2019

Filed:

Jun 13, 2017

Appl. No.:

16/309019

Inventors:

- Detroit MI, US
Stanley FRINAK - Farmington Hills MI, US
Jerry YEE - Beverly Hills MI, US
Anatole BESARAB - Bloomfield Hills MI, US
John B. KENNEDY - Evanston IL, US
Jeffrey J. SANDS - Orlando FL, US

Assignee:

HENRY FORD HEALTH SYSTEM - Detroit MI

International Classification:

A61M 1/16

Abstract:

A method of detecting intravascular volume depletion in a patient during a hemodialysis session includes measuring venous drip pressure for the patient. With a computer-driven analyzer, the method further includes analyzing the venous drip pressure and automatically and continuously determining a venous access pressure in proximity to a location of needle insertion into a vascular access site of the patient, wherein changes in venous access pressure are representative of changes in intravascular blood pressure. Using the analyzer, the method further includes comparing the venous access pressure to a standard and, if the venous access pressure is outside of a defined range of the standard, determining with the analyzer that the patient is experiencing intravascular volume depletion during the hemodialysis session.